Tuoxin Pharmaceutical
30108922.552.04% ( +0.45 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Tuoxin Pharmaceutical(301089) the Revenue is 92.5 M (-4.63%);the EBIT is -8.813 M (-67.98%);the EPS is -0.08 (-166.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.09B4.63%
----
----
EBIT
-0.01B67.98%
----
----
EPS
-0.08166.67%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf